ARIX.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 Feb 2024 @ 12:15):

Stats
Today's Volume	13.86M
Average Volume	462 154
Market Cap	183.73M
EPS	£0 ( 2024-04-22 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	12.91
ATR14	£2.89 (2.03%)

Volume Correlation

Long: 0.24 (neutral)

Short: -0.87 (strong negative)

Signal:(69.448) Neutral

Arix Bioscience PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Arix Bioscience PLC Correlation - Currency/Commodity

0.76
( moderate )

0.52
( weak )

-0.89
( strong negative )

0.74
( moderate )

0.07
( neutral )

Arix Bioscience PLC Financials

Annual	2022
Revenue:	£112 000
Gross Profit:	£112 000 (100.00 %)
EPS:	£-0.210

FY	2022
Revenue:	£112 000
Gross Profit:	£112 000 (100.00 %)
EPS:	£-0.210

FY	2021
Revenue:	£340 000
Gross Profit:	£0.00 (0.00 %)
EPS:	£-0.582

FY	2020
Revenue:	£477 000
Gross Profit:	£0.00 (0.00 %)
EPS:	£0.968

Financial Reports:

No articles found.

Arix Bioscience PLC Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Arix Bioscience PLC

Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.